Skip to content
Clinical Trials – home

Cefoxitin: A Comprehensive Guide for Patients

3 / 3
trials open to patients / all trials
2+
Countries

In short

Cefoxitin, a second-generation cephalosporin antibiotic, is being studied in several clinical trials for its effectiveness in treating various infections and as a prophylactic measure in surgical procedures. These trials aim to evaluate cefoxitin's efficacy, safety, and optimal dosing strategies in different patient populations and medical conditions.

At a glance

Main Indications
ESBL-producing E. coli infections, surgical prophylaxis
Administration Methods
Intravenous bolus, continuous infusion, intermittent dosing
Key Advantages
Effective against ESBL-producing bacteria, narrower spectrum, potential cost savings
Special Populations
Obese patients undergoing bariatric surgery
Outcome Measures
Clinical/microbiological response, SSI rates, pharmacokinetics, antibiotic resistance
Comparative Studies
Cefoxitin vs. imipenem/cilastatin, cefoxitin vs. piperacillin-tazobactam
Dosing Strategies
Varied by trial and patient population (e.g., 2g every 6 hours, 4g loading dose in obese patients)

What is Cefoxitin?

Cefoxitin is an antibiotic medication that belongs to a class of drugs called cephamycins. It's a type of beta-lactam antibiotic, which means it's related to penicillin but has some unique properties that make it effective against certain types of bacteria. Cefoxitin was developed in the 1970s but has gained renewed interest in recent years due to its effectiveness against certain antibiotic-resistant bacteria.

Uses of Cefoxitin

Cefoxitin is used to treat or prevent various types of bacterial infections. Some of the common uses include:

  • Surgical site infections: Cefoxitin is often used to prevent infections after certain types of surgery, particularly abdominal surgeries like colorectal surgery and pancreatic surgery.
  • Urinary tract infections: It's being studied for use in treating urinary tract infections caused by certain antibiotic-resistant bacteria.
  • Pelvic infections: Cefoxitin may be used to prevent infections after childbirth, particularly in women who have had complicated deliveries.
  • Appendicitis: Some studies are exploring whether cefoxitin can be used as part of antibiotic treatment for appendicitis, potentially avoiding the need for surgery in some cases.

How Cefoxitin Works

Cefoxitin works by interfering with the way bacteria build their cell walls. It has a special structure that includes an alpha-methoxy group, which makes it resistant to certain enzymes (called beta-lactamases) that some bacteria use to defend themselves against antibiotics. This means cefoxitin can be effective against some bacteria that have become resistant to other antibiotics.

Administration Methods

Cefoxitin is typically given in a hospital setting, usually through an intravenous (IV) line directly into the bloodstream. The dosage and duration of treatment can vary depending on the type and severity of the infection being treated. Some common administration methods include:

  • Single dose: For preventing surgical infections, cefoxitin is often given as a single dose shortly before surgery.
  • Multiple doses: For treating active infections, cefoxitin may be given every 6-8 hours for several days.
  • Continuous infusion: Some studies are exploring whether giving cefoxitin as a continuous infusion might be more effective for preventing infections.

Effectiveness and Ongoing Research

Cefoxitin has been shown to be effective against many types of bacteria, including some that are resistant to other antibiotics. However, researchers are continually studying how to use it most effectively. Some areas of ongoing research include:

  • Optimal dosing: Studies are looking at the best ways to give cefoxitin, including how much to give and how often.
  • Comparison with other antibiotics: Researchers are comparing cefoxitin to other antibiotics to see which is most effective for different types of infections.
  • Use in specific patient groups: Some studies are looking at how well cefoxitin works in specific groups of patients, such as obese patients undergoing surgery or HIV-positive women giving birth.

Potential Side Effects

Like all medications, cefoxitin can cause side effects in some people. Common side effects may include nausea, diarrhea, or pain at the injection site. More serious side effects are rare but can include allergic reactions or severe diarrhea. It's important to discuss potential side effects with your healthcare provider before receiving cefoxitin.

Questions people often ask

Conditions where Cefoxitin is being studied

Each condition opens its own overview and trial list

Trials with Cefoxitin

Recruiting trials first

See all 3 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).